2/ The author team & an information specialist searched for studies:
✅ that compared lower #BloodPressure targets to standard bp🎯
✅ which included people with #hypertension and #CVD (heart disease, angina, stroke, vascular disease)
✅RCTs with more than 50 people/group
✅Minimum 6 months follow‐up
✅Data for at least 1 primary outcome (total mortality, serious adverse events, total cardiovascular events, cardiovascular mortality)
✅Total deaths, or in heart or vascular deaths between lower & standard bp goals
✅Total number of heart or vascular problems and total serious harms (but the evidence was less certain)
6/ Implications for clinician practice:
Evidence identified in this review does not support lower bp 🎯 (less than 135/85 mmHg) as compared to standard bp 🎯 (less than 140-160 mmHg/90-100 mmHg) in people with #hypertension & established #cvd
Well‐designed RCTs assessing lower bp 🎯 in people with #hypertension#CVD are needed to ascertain benefits/harms derived from intensive & more conservative strategies
Future research should report mortality rates & all serious adverse events
• • •
Missing some Tweet in this thread? You can try to
force a refresh
THREAD: Are we using ACEIs & ARBs properly? A TI Tweetorial
1/6: British Columbia doctors give 4.5m scripts/year for ACE inhibitors (ACEIs) & angiotensin receptor blockers (ARBs) to control bp. Goal is to ↘️ mortality & morbidity, not simply to ↘️ bp.
Both ACEIs & ARBs ↘️ blood pressure to similar extents.... BUT only ACEIs have evidence for a reduction in risk of morbidity & mortality. So they’d be your first choice 🥇
Hypertension (high blood pressure) is a very common condition, and is associated with increased 📈 risk for strokes, heart attacks and premature death, so it's worth asking some questions 🤔
Screening for high blood pressure might not be that helpful 😯 and early🕗detection of mild hypertension may not significantly impact health‐related costs in the long term nor improve health outcomes: bit.ly/35P2mcz